REMISSION
Clinical trials for REMISSION explained in plain language.
Never miss a new study
Get alerted when new REMISSION trials appear
Sign up with your email to follow new studies for REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Crohn's remission patients may ditch daily pills without Flare-Up risk
Disease control OngoingThis study looks at whether people with Crohn's disease who are in remission can safely stop taking aminosalicylate (5-ASA) medication. About 334 participants will either continue or stop their 5-ASA therapy and be monitored for two years to see if stopping leads to more complica…
Matched conditions: REMISSION
Phase: PHASE4 • Sponsor: Alimentiv Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Can algorithms predict psychosis before it strikes?
Knowledge-focused OngoingThis observational study follows 2,617 young people (ages 12-30) who are at clinical high risk for psychosis, along with healthy volunteers, for up to two years. Researchers collect clinical assessments, cognitive tests, and biomarkers to build algorithms that can predict who wil…
Matched conditions: REMISSION
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:04 UTC